Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder

Sandipan Bhattacharjee,1 Jeannie K Lee,1 Nina Vadiei,1 Asad E Patanwala,2 Daniel C Malone,3 Shannon M Knapp,4 Wei-Hsuan Lo-Ciganic,5 William J Burke6 1Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ, USA; 2Sydney Pharmacy School, University of...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Bhattacharjee S, Lee JK, Vadiei N, Patanwala AE, Malone DC, Knapp SM, Lo-Ciganic WH, Burke WJ
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2020
Materias:	dementia depression antidepressants adherence acute phase depression continuation phase depression Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/8be5e72213844e48a6eb632b61d35c34
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8be5e72213844e48a6eb632b61d35c34
record_format	dspace
spelling	oai:doaj.org-article:8be5e72213844e48a6eb632b61d35c342021-12-02T09:33:12ZExtent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder1178-2021https://doaj.org/article/8be5e72213844e48a6eb632b61d35c342020-06-01T00:00:00Zhttps://www.dovepress.com/extent-and-factors-associated-with-adherence-to-antidepressant-treatme-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Sandipan Bhattacharjee,1 Jeannie K Lee,1 Nina Vadiei,1 Asad E Patanwala,2 Daniel C Malone,3 Shannon M Knapp,4 Wei-Hsuan Lo-Ciganic,5 William J Burke6 1Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ, USA; 2Sydney Pharmacy School, University of Sydney, Sydney, Australia; 3Department of Pharmacotherapy, Skaggs College of Pharmacy, University of Utah, Salt Lake City, UT, USA; 4Statistics Consulting Laboratory, Bio5 Institute, The University of Arizona, Tucson, AZ, USA; 5Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA; 6Banner Alzheimer’s Institute, Phoenix, AZ, USACorrespondence: Sandipan BhattacharjeeDepartment of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tucson, AZ, USATel +1 520 626-4124Fax +1 520-626-7355Email bhattacharjee@pharmacy.arizona.eduPurpose: Little is known about adherence to antidepressant treatment during acute and continuation phase of depression among older adults with dementia and newly diagnosed major depressive disorders (MDD). This study estimated the extent of and factors associated with adherence to acute and continuation phase antidepressant treatment among older adults with dementia and newly diagnosed MDD.Methods: We conducted a retrospective cohort study using the Medicare 5% sample claims data (2012– 2013) among older adults (age≥ 65 years) with dementia who were newly diagnosed with MDD. Intake period of our study was from 01-May-2012 through 30-April-2013. The dependent variables of this study were acute and continuation phase depression treatment adherence. Factors associated with acute and continuation phase antidepressant treatment adherence were identified using multiple logistic regression analyses.Results: The final study sample consisted of 6239 [adherent: N=4644 (74.44%)] and 5617 [adherent: N=3584 (63.81%)] older adults with dementia and MDD during the acute and continuation phase treatment, respectively. During the acute phase, only race/ethnicity was significantly associated with adherence to depression treatment, whereas race/ethnicity and baseline antipsychotic use were significantly associated with adherence to depression treatment during the continuation phase.Conclusion: Approximately, 74% and 64% older adults with dementia and MDD were adherent to acute and continuation phase antidepressant treatment in this nationally representative sample of Medicare beneficiaries, and we identified several modifiable and non-modifiable factors associated with adherence.Keywords: dementia, depression, antidepressants, adherence, acute phase depression, continuation phase depressionBhattacharjee SLee JKVadiei NPatanwala AEMalone DCKnapp SMLo-Ciganic WHBurke WJDove Medical Pressarticledementiadepressionantidepressantsadherenceacute phase depressioncontinuation phase depressionNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 16, Pp 1433-1450 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	dementia depression antidepressants adherence acute phase depression continuation phase depression Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	dementia depression antidepressants adherence acute phase depression continuation phase depression Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Bhattacharjee S Lee JK Vadiei N Patanwala AE Malone DC Knapp SM Lo-Ciganic WH Burke WJ Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
description	Sandipan Bhattacharjee,1 Jeannie K Lee,1 Nina Vadiei,1 Asad E Patanwala,2 Daniel C Malone,3 Shannon M Knapp,4 Wei-Hsuan Lo-Ciganic,5 William J Burke6 1Department of Pharmacy Practice and Science, College of Pharmacy, The University of Arizona, Tucson, AZ, USA; 2Sydney Pharmacy School, University of Sydney, Sydney, Australia; 3Department of Pharmacotherapy, Skaggs College of Pharmacy, University of Utah, Salt Lake City, UT, USA; 4Statistics Consulting Laboratory, Bio5 Institute, The University of Arizona, Tucson, AZ, USA; 5Department of Pharmaceutical Outcomes & Policy, College of Pharmacy, University of Florida, Gainesville, FL, USA; 6Banner Alzheimer’s Institute, Phoenix, AZ, USACorrespondence: Sandipan BhattacharjeeDepartment of Pharmacy Practice and Science, The University of Arizona College of Pharmacy, Tucson, AZ, USATel +1 520 626-4124Fax +1 520-626-7355Email bhattacharjee@pharmacy.arizona.eduPurpose: Little is known about adherence to antidepressant treatment during acute and continuation phase of depression among older adults with dementia and newly diagnosed major depressive disorders (MDD). This study estimated the extent of and factors associated with adherence to acute and continuation phase antidepressant treatment among older adults with dementia and newly diagnosed MDD.Methods: We conducted a retrospective cohort study using the Medicare 5% sample claims data (2012– 2013) among older adults (age≥ 65 years) with dementia who were newly diagnosed with MDD. Intake period of our study was from 01-May-2012 through 30-April-2013. The dependent variables of this study were acute and continuation phase depression treatment adherence. Factors associated with acute and continuation phase antidepressant treatment adherence were identified using multiple logistic regression analyses.Results: The final study sample consisted of 6239 [adherent: N=4644 (74.44%)] and 5617 [adherent: N=3584 (63.81%)] older adults with dementia and MDD during the acute and continuation phase treatment, respectively. During the acute phase, only race/ethnicity was significantly associated with adherence to depression treatment, whereas race/ethnicity and baseline antipsychotic use were significantly associated with adherence to depression treatment during the continuation phase.Conclusion: Approximately, 74% and 64% older adults with dementia and MDD were adherent to acute and continuation phase antidepressant treatment in this nationally representative sample of Medicare beneficiaries, and we identified several modifiable and non-modifiable factors associated with adherence.Keywords: dementia, depression, antidepressants, adherence, acute phase depression, continuation phase depression
format	article
author	Bhattacharjee S Lee JK Vadiei N Patanwala AE Malone DC Knapp SM Lo-Ciganic WH Burke WJ
author_facet	Bhattacharjee S Lee JK Vadiei N Patanwala AE Malone DC Knapp SM Lo-Ciganic WH Burke WJ
author_sort	Bhattacharjee S
title	Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
title_short	Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
title_full	Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
title_fullStr	Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
title_full_unstemmed	Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder
title_sort	extent and factors associated with adherence to antidepressant treatment during acute and continuation phase depression treatment among older adults with dementia and major depressive disorder
publisher	Dove Medical Press
publishDate	2020
url	https://doaj.org/article/8be5e72213844e48a6eb632b61d35c34
work_keys_str_mv	AT bhattacharjees extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder AT leejk extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder AT vadiein extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder AT patanwalaae extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder AT malonedc extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder AT knappsm extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder AT lociganicwh extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder AT burkewj extentandfactorsassociatedwithadherencetoantidepressanttreatmentduringacuteandcontinuationphasedepressiontreatmentamongolderadultswithdementiaandmajordepressivedisorder
_version_	1718398076006170624

Extent and Factors Associated with Adherence to Antidepressant Treatment During Acute and Continuation Phase Depression Treatment Among Older Adults with Dementia and Major Depressive Disorder

Ejemplares similares